Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

被引：1205

作者：

Brozek, Jan L. ^{[1
]}

Bousquet, Jean ^{[2
,3
,4
]}

Baena-Cagnani, Carlos E. ^{[5
]}

Bonini, Sergio ^{[6
,7
]}

Canonica, G. Walter ^{[8
]}

Casale, Thomas B. ^{[9
]}

van Wijk, Roy Gerth ^{[10
]}

Ohta, Ken ^{[11
]}

Zuberbier, Torsten ^{[12
]}

Schuenemann, Holger J. ^{[1
]}

机构：

[1] McMaster Univ, Dept Clin Epidemiol & Biostat & Med, Hamilton, ON L8N 3Z5, Canada

[2] Hop Arnaud Villeneuve, Serv Malad Resp, Montpellier, France

[3] INSERM, CESP U1018, Resp & Environm Epidemiol Team, Montpellier, France

[4] WHO Collaborating Ctr Rhinitis & Asthma, Montpellier, France

[5] Catholic Univ Cordoba, Fac Med, Cordoba, Argentina

[6] CNR, Inst Neurobiol & Mol Med, Rome, Italy

[7] Univ Naples 2, Dept Med, Naples, Italy

[8] Univ Genoa, Dept Internal Med, DIMI, I-16126 Genoa, Italy

[9] Creighton Univ, Dept Med, Div Allergy & Immunol, Omaha, NE 68178 USA

[10] Erasmus MC, Dept Internal Med, Sect Allergol, Rotterdam, Netherlands

[11] Teikyo Univ, Sch Med, Dept Med, Div Resp Med & Allergol, Tokyo 173, Japan

[12] Charite, Dept Dermatol & Allergy, D-13353 Berlin, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2010年 / 126卷 / 03期

关键词：

AR; practice guideline; QUALITY; MANAGEMENT; STRENGTH; GRADE; RECOMMENDATIONS; COLLABORATION; UPDATE;

D O I：

10.1016/j.jaci.2010.06.047

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Background: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. Objective: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. Methods: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. Results: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. Conclusion: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. (J Allergy Clin Immunol 2010;126:466-76.)

引用

页码：466 / 476

页数：11

共 21 条

[1] Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three [J].

Ait-Khaled, N. ;

Pearce, N. ;

Anderson, H. R. ;

Ellwood, P. ;

Montefort, S. ;

Shah, J. .

ALLERGY, 2009, 64 (01) :123-148

[2] Allergic rhinitis management pocket reference 2008 [J].

Bousquet, J. ;

Reid, J. ;

van Weel, C. ;

Cagnani, C. Baena ;

Canonica, G. W. ;

Demoly, P. ;

Denburg, J. ;

Fokkens, W. J. ;

Grouse, L. ;

Mullol, K. ;

Ohta, K. ;

Schermer, T. ;

Valovirta, E. ;

Zhong, N. ;

Zuberbier, T. .

ALLERGY, 2008, 63 (08) :990-996

[3] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) [J].

Bousquet, J. ;

Khaltaev, N. ;

Cruz, A. A. ;

Denburg, J. ;

Fokkens, W. J. ;

Togias, A. ;

Zuberbier, T. ;

Baena-Cagnani, C. E. ;

Canonica, G. W. ;

van Weel, C. ;

Agache, I. ;

Ait-Khaled, N. ;

Bachert, C. ;

Blaiss, M. S. ;

Bonini, S. ;

Boulet, L. -P. ;

Bousquet, P. -J. ;

Camargos, P. ;

Carlsen, K. -H. ;

Chen, Y. ;

Custovic, A. ;

Dahl, R. ;

Demoly, P. ;

Douagui, H. ;

Durham, S. R. ;

van Wijk, R. Gerth ;

Kalayci, O. ;

Kaliner, M. A. ;

Kim, Y. -Y. ;

Kowalski, M. L. ;

Kuna, P. ;

Le, L. T. T. ;

Lemiere, C. ;

Li, J. ;

Lockey, R. F. ;

Mavale-Manuel, S. ;

Meltzer, E. O. ;

Mohammad, Y. ;

Mullol, J. ;

Naclerio, R. ;

Hehir, R. E. O. ;

Ohta, K. ;

Ouedraogo, S. ;

Palkonen, S. ;

Papadopoulos, N. ;

Passalacqua, G. ;

Pawankar, R. ;

Popov, T. A. ;

Rabe, K. F. ;

Rosado-Pinto, J. .

ALLERGY, 2008, 63 :8-+

[4] Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN) [J].

Bousquet, J. ;

van Cauwenberge, P. ;

Khaled, N. Ait ;

Bachert, C. ;

Baena-Cagnani, C. E. ;

Bouchard, J. ;

Bunnag, C. ;

Canonica, G. W. ;

Carlsen, K. -H. ;

Chen, Y. -Z. ;

Cruz, A. A. ;

Custovic, A. ;

Demoly, P. ;

Dubakiene, R. ;

Durham, S. ;

Fokkens, W. ;

Howarth, P. ;

Kemp, J. ;

Kowalski, M. L. ;

Kvedariene, V. ;

Lipworth, B. ;

Lockey, R. ;

Lund, V. ;

Mavale-Manuel, S. ;

Meltzer, E. O. ;

Mullol, J. ;

Naclerio, R. ;

Nekam, K. ;

Ohta, K. ;

Papadopoulos, N. ;

Passalacqua, G. ;

Pawankar, R. ;

Popov, T. ;

Potter, P. ;

Price, D. ;

Scadding, G. ;

Simons, F. E. R. ;

Spicak, V. ;

Valovirta, E. ;

Wang, D. -Y. ;

Yawn, B. ;

Yusuf, O. .

ALLERGY, 2006, 61 (09) :1086-1096

[5]

Bousquet J, 2004, ALLERGY, V59, P373

[6] Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial [J].

Bousquet, J ;

Lund, VJ ;

van Cauwenberge, P ;

Bremard-Oury, C ;

Mounedji, N ;

Stevens, MT ;

El-Akkad, T .

ALLERGY, 2003, 58 (08) :733-741

[7] Allergic rhinitis and its impact on asthma [J].

Bousquet, J ;

van Cauwenberge, P ;

Khaltaev, N ;

Ait-Khaled, N ;

Annesi-Maesano, I ;

Bachert, C ;

Baena-Cagnani, C ;

Bateman, E ;

Bonini, S ;

Canonica, GW ;

Carlsen, KH ;

Demoly, P ;

Durham, SR ;

Enarson, D ;

Fokkens, WJ ;

van Wijk, RG ;

Howarth, P ;

Ivanova, NA ;

Kemp, JP ;

Klossek, JM ;

Lockey, RF ;

Lund, V ;

Mackay, I ;

Malling, HJ ;

Meltzer, EO ;

Mygind, N ;

Okunda, M ;

Pawankar, R ;

Price, D ;

Scadding, GK ;

Simons, FER ;

Szczeklik, A ;

Valovirta, E ;

Vignola, AM ;

Wang, DY ;

Warner, JO ;

Weiss, KB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (05) :S147-S334

[8] Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 update [J].

Brozek, J. L. ;

Baena-Cagnani, C. E. ;

Bonini, S. ;

Canonica, G. W. ;

Rasi, G. ;

van Wijk, R. G. ;

Zuberbier, T. ;

Guyatt, G. ;

Bousquet, J. ;

Schuenemann, H. J. .

ALLERGY, 2008, 63 (01) :38-46

[9] Grading quality of evidence and strength of recommendations in clinical practice guidelines [J].

Brozek, J. L. ;

Akl, E. A. ;

Alonso-Coello, P. ;

Lang, D. ;

Jaeschke, R. ;

Williams, J. W. ;

Phillips, B. ;

Lelgemann, M. ;

Lethaby, A. ;

Bousquet, J. ;

Guyatt, G. H. ;

Schuenemann, H. J. .

ALLERGY, 2009, 64 (05) :669-677

[10] Risk of first-generation H1-antihistamines: a GA2LEN position paper [J].

Church, M. K. ;

Maurer, M. ;

Simons, F. E. R. ;

Bindslev-Jensen, C. ;

van Cauwenberge, P. ;

Bousquet, J. ;

Holgate, S. T. ;

Zuberbier, T. .

ALLERGY, 2010, 65 (04) :459-466

← 1 2 3 →